Free Trial

Kiniksa Pharmaceuticals (KNSA) SEC Filings & 10K Form

$18.67
-0.37 (-1.94%)
(As of 05/29/2024 ET)

Recent Kiniksa Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/07/2024
3:46 PM
Kiniksa Pharmaceuticals (Issuer)
Levy Richard S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
3:35 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
3:36 PM
Kiniksa Pharmaceuticals (Filer)
Form DEF 14A
04/23/2024
3:41 PM
Kiniksa Pharmaceuticals (Filer)
Form ARS
04/23/2024
3:43 PM
Kiniksa Pharmaceuticals (Filer)
Form DEFA14A
04/23/2024
3:46 PM
Kiniksa Pharmaceuticals (Filer)
Form DEFA14A
04/23/2024
6:34 AM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
4:00 PM
Kiniksa Pharmaceuticals (Filer)
Form PRE 14A
04/08/2024
4:20 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
4:21 PM
Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
4:22 PM
Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
4:17 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
4:18 PM
Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
4:19 PM
Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
11:21 AM
BlackRock Inc. (Filed by)
Kiniksa Pharmaceuticals (Subject)
Form SC 13G/A
04/03/2024
4:22 PM
Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
4:23 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
4:25 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
6:32 AM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
4:00 PM
Kiniksa Pharmaceuticals (Filer)
Form DEFA14A
03/29/2024
6:30 AM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
6:30 AM
Kiniksa Pharmaceuticals (Filer)
Form DEFA14A
03/11/2024
6:05 PM
Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:37 PM
Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:24 PM
Kiniksa Pharmaceuticals (Subject)
Patel Sanj K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
5:26 PM
Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:29 PM
Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
4:31 PM
Kiniksa Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2024
6:35 AM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
2:46 PM
Fairmount Funds Management LLC (Filed by)
Kiniksa Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2024
5:06 AM
Kiniksa Pharmaceuticals (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G
01/04/2024
6:37 AM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2023
3:26 PM
Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
3:20 PM
Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
3:46 PM
Kiniksa Pharmaceuticals (Subject)
Paolini John F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2023
3:33 PM
Kiniksa Pharmaceuticals (Issuer)
Levy Richard S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
3:15 PM
Kiniksa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2023
6:35 AM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2023
3:26 PM
Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
6:03 PM
Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
6:04 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Gold Set to EXPLODE! (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!
09/06/2023
6:06 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
6:06 PM
Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
6:07 PM
Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
6:08 PM
Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
4:26 PM
Kiniksa Pharmaceuticals (Subject)
Paolini John F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2023
3:32 PM
HHLR ADVISORS, LTD. (Filed by)
Kiniksa Pharmaceuticals (Subject)
Form SC 13G/A
07/25/2023
6:40 AM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2023
3:15 PM
Kiniksa Pharmaceuticals (Issuer)
Quart Barry D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:15 PM
Cole G Bradley (Reporting)
Kiniksa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:15 PM
Kiniksa Pharmaceuticals (Issuer)
Popovits Kimberly J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:15 PM
Kiniksa Pharmaceuticals (Issuer)
Levy Richard S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:15 PM
Kiniksa Pharmaceuticals (Issuer)
McCain Tracey L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:15 PM
Kiniksa Pharmaceuticals (Issuer)
Malley Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
4:37 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Kiniksa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
4:09 PM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:KNSA) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners